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Background: International migration to middle-income countries is increasing and its health consequences, in
particular increasing transmission rates of tuberculosis (TB), deserve consideration. Migration and TB are a matter of
concern in high-income countries and targeted screening of migrants for active and latent TB infection is a main
strategy to manage risk and minimize transmission. In this paper, we discuss some aspects of TB control and
migration in the context of middle-income countries, together with the prospect of responding with equitable and
comprehensive policies.
Main body: TB rates in middle-income countries remain disproportionally high among the poorest and most
vulnerable groups in large cities where most migrant populations are concentrated. Policies that tackle migrant
TB in high-income countries may be inadequate for middle-income countries because of their different socio-
economic and cultural scenarios. Strategies to control TB in these settings must take into account the characteristics
of middle-income countries and the complexity of TB as a disease of poverty. Intersectoral policies of social
protection such as cash-transfer programs help reducing poverty and improving health in vulnerable populations.
We address the development of new approaches to improve well-established strategies including contact tracing
and active and latent TB screening as an ‘add on’ to the existing health care guidelines of conditional cash transfer
programs. In addition, we discuss how it might improve health and welfare among both poor migrants and
locally-born populations. Authorities from middle-income countries should recognise that migrants are a vulnerable
social group and promote cooperation efforts between sending and receiving countries for mitigation of poverty
and prevention of disease in this group.
Conclusions: Middle-income countries have long sent migrants overseas. However, the influx of large migrant
populations into their societies is relatively new and a growing phenomenon and it is time to set comprehensive
goals to improve health among these communities. Conditional cash transfer policies with TB screening and
strengthening of DOTS are some strategies that deserve attention. Reduction of social and health inequality among
migrants should be incorporated into concerted actions to meet TB control targets.
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Background
Tuberculosis (TB) rates have declined significantly in the
20th century worldwide, but HIV and multidrug-resistant
tuberculosis (MDR-TB) have had drastic effects in some
of the poorest countries [1, 2]. TB burden is still much
higher in the poorest economies and highly concentrated
among vulnerable1 populations and specific groups such
as homeless people, people living with HIV (PLHIV),
prisoners and migrants [1, 3]. It has been a century of
reawakening concerns about TB control and rebuilding
strategies for the next decades.
TB and TB/HIV coinfection partially reflects the in-
come and development level of a country, with medium
incidence rates at least 20 times higher in low-income
countries (LIC) than in high-income countries (HIC)
(Fig. 1) [1, 4]. Incidence of TB and associated mortality
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are now low in most HIC, with TB risk being dispropor-
tionally high among migrants from high burden coun-
tries—up to 80% of cases reported in some receiving
countries [5]. Migrants are a risk group for TB from the
perspective of the receiving country as TB incidence
rates among them usually reflect TB incidence in the
country of origin [6].
In HIC, migrants from high TB burden countries
typically maintain higher active TB prevalences com-
pared to the local population and, TB prevalence can
reach at 3.3/1000 among migrants [7]. It may reflect a
higher proportion of latent TB infection (LTBI) and in-
creased risk of disease reactivation potentially increasing
the risk of transmission to local communities. Migrants
are often a hard-to-reach group, and thus poses a major
challenge for TB control in high-income countries.
Over the last 15 years, the economic development of
Upper-middle income countries (UMIC), especially the
BRICS (Brazil, Russia2, India, China and South Africa)
[1], has led to an increase in health spending and
strengthening of primary care services [8]. Many regions
have either achieved or made gains in achieving the TB-
related Millennium Development Goals [1], but in con-
trast to the developed world, TB rates in some countries
have remained high due to sustained poverty and poor
living conditions [9]. Today, a great difference in TB
rates remains between UMIC and Low-middle Income
countries (LMIC) (Fig. 1).
Most South American countries have robust TB
control programs, but inner-city populations often live
in areas of deprivation with high unemployment rates
and high rates of TB-related morbidity and mortality [1].
This is common even in countries with sound economic
development such as Argentina, Brazil and Chile that
attract a high number of regional migrants from other
middle-income countries [10–12]. Migration and TB
control strategies in middle-income countries, especially
in UMIC, need further investigation taking into consi-
deration this context.
Migration, vulnerability and TB
As part of economic globalization, since the 1980s there
has been an intensification of migration. Migrants living
in developing regions accounted for 42% of total migra-
tion stock in 2015 and South-South3 migration now
comprises 36% of total migration, a proportion that is
higher than that of South–north migration [13]. Figure 2
shows total number of migrants by country according to
UN [13]. Refugees from conflict areas and natural disasters
are highly visible in the media, but half of the migration
stock (106 million) are international labour migrants who
may live in an irregular situation in the receiving country
[14]. Violence, labour exploitation and sexual harassment
are frequently reported as occurring during the migration
journey and in the country of destination [2, 14]. Stressful
conditions and social vulnerability can contribute to the
Fig. 1 Median TB incidence rate/100,000 person-year for each group of country (High, Upper-middle, Low-middle and Low-Income Countries)*
1990–2014. *Median incidence was calculated using panel data, collapsing countries and calculating the median TB incidence by group of
country/year. Source: Tuberculosis data extracted from WHO [1]. World Bank [4] was used to classify country groups
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development of non-infectious and infectious diseases
in migrants, including TB infection or LTBI reactiva-
tion [15, 16].
Host societies are increasingly concerned with social
and economic impacts of migration including potential
effects on morbidity and mortality and the burden on
health care services (especially when accurate migration
data are not available) [14]. The recent international
financial crisis and austerity policies in the developed
world have accentuated social inequities and affected
migrants disproportionately [15].
Migration in middle-income countries is generally
directed to major cities [17, 18]. Migrants are more
likely to settle in low-income inner-city neighbourhoods
with the greatest TB burden and some migrant groups
often face more poverty, vulnerability and social exclu-
sion than native communities living in the same areas
[19]. In large cities in middle-income countries with
large inequalities and high proportions of HIV, homeless
individuals and drug users [1, 5], migrants comprise a
new risk group for TB burden that needs to be specific-
ally targeted.
Tuberculosis control among migrants
Screening for active and latent TB infection
In addition to strengthening Direct Observed Treatment,
Short-Course (DOTS) strategy and Bacillus Calmette–
Guérin (BCG) vaccination among migrants since the
1980s, many high-income countries with low TB burden
have also incorporated active and latent TB screening. TB
screening strategies directed to migrants are aimed to re-
duce TB burden and the risk of TB transmission: migrant
screening for LTBI is estimated to prevent many new TB
cases [20], potentially reducing the risk of transmission in
the community whereas screening for active TB is thought
to prevent more severe forms of TB and reduce treatment
costs [21]. There is no consensus on the most appropriate
screening strategy: screening for active TB and/or LTBI;
pre-arrival, post-arrival or screening in the community;
use of chest X-rays (CXR) and/or IGRA [5]. Screening
strategies based on TB incidence in the country of origin
or on the type of migration—asylum seekers/refugees—is
also a common approach [22]. The cost-effectiveness of
each screening strategy is determined by TB epidemiology
in the country of origin or type of migration [16].
While some HIC have chosen compulsory screening for
some types of migrants, others do not consider screening
[22]. The decision for not performing screening is usually
motivated by lack of financial aid, low yield in areas with
high presence of irregular migrants (who are less
frequently screened), and ethical considerations [22, 23].
The strategies for TB control in migrant populations
in middle-income countries are poorly discussed in the
literature. TB control in middle-income countries is
more complex due to multifaceted problems such as
poverty, inequality and higher infectious disease rates in
locally born populations. It is known that the prevalence
of LTBI is likely to be higher in low- and middle-income
countries than in high-income countries. In Brazil, active
and latent TB screening is only suggested for contacts of
TB patients, for HIV-infected individuals, the homeless
and prisoners (and treatment for LTBI is not always
recommended) [24]. The estimated prevalence of LTBI
was 60% among contacts of TB patients living in urban
areas [25]. To consider migrants from high-incidence TB
countries as risk groups for TB and to target them for
screening may result in increased case detection and
treatment coverage. But in contrast to high-income
countries, screening for active TB and even LTBI in
migrants in low- and middle-income countries may be
more critical as incidence in migrants might be as high
as that seen in poor inner-city populations [10, 26].
Fig. 2 Number of international migrants in 2015. Source: Adapted from United Nations (UN, [13])
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Another issue is that targeting migrants may have a
discriminatory effect. Moreover, irregular migrants may
not respond to these policies for fear of detection and
criminal conviction or expulsion [27]. In order to over-
come potential resistance to screening, free access to
treatment and hospital admissions for TB cases among
migrants must be guaranteed regardless of migration
status [28].
Tuberculosis diagnosis and treatment among migrants
TB-related Millennium Development Goals have
brought substantial improvements in implementation of
free diagnosis and TB treatment [1]. In Brazil, it was
suggested that adding an intensive screening of house-
hold contacts of TB patients for active or latent TB
infection to DOTS would reduce by 15% TB incidence
in 5 years [25]. It further suggests that the strengthening
of existing tools, as suggested in DOTS—though not
fully implemented in several countries—might be
effective in improving TB diagnosis and treatment in
high-risk groups including migrants.
Although the proportion of cases of TB among
migrants in middle-income countries is unknown, we
estimate they account for a small proportion of cases.
Few studies estimated the burden of TB among migrants
in MIC, although migration has been increasingly im-
portant for disease control [26, 29–31], especially among
the poorest and most vulnerable migrants. Institutional
and skilled capacity to assist migrants need to be
strengthened to deal with increasing migration flows
from higher TB burden countries to large urban centres
in MIC to ensure the provision of quality health care.
However, the level of this demand is not yet clearly
understood.
Free access to TB diagnosis and treatment has been
implemented among migrants in many high-income
countries, but access to health care can be especially dif-
ficult. Migrants face many social and cultural barriers to
accessing treatment and sometimes they experience
prejudice in health care settings [15]. Policies of free and
universal access to health ensuring access for migrants
has been a determinant for health equity promotion
among South American migrants in large urban centres
in Brazil [26]. Health care programs targeting specific
groups in Latin American countries have contributed to
improved access to health care [32], but the capacity
of non-universal health systems to provide care to
migrants may still be subjected to the current policy
of a given country.
MDR-TB is currently a major challenge for TB control
[1]. Migration from regions with high rates of MDR-TB
is inevitable and potential issues must be addressed
when planning control strategies. High coverage of drug
susceptibility test (DST) among migrant populations
must be achieved. MDR-TB rates are low in the Americas,
which contrasts with high rates observed in sub-Saharan
Africa and India [1]. Mathematical models have been in-
creasingly built to understand TB transmission and health
and economic impact of new tools and strategies for TB
control including those for MDR-TB detection and treat-
ment [33].
It is crucial for TB control to consider the characteris-
tics of migrants in MIC, their interaction and social
impact on host societies. Heterogeneity in TB incidence
across different risk groups has been suggested as playing
an important role in maintaining disease transmission,
indicating that universal control measures are doomed to
have limited impact if social inequalities are maintained
[11, 34].
Social protection policies
Conditional cash transfer programs have been successfully
implemented in several high-, middle- and low-income
countries in the past decade. Although inclusion criteria
and benefits vary, these programs are usually integrated
into education and health care policies. For example, the
Brazilian conditional cash transfer (CCT) program “Bolsa
Família” [35] provides families who have a per capita
monthly income below USD 50 with a monthly stipend
per child under 18. This is conditional on children attend-
ing school and family members seeking preventive care.
This policy has had a positive impact on nutrition and
food security of families, maternal and child mortality,
utilization of health care services, and social determinants
of some infectious diseases such as leprosy [35, 36]. The
Mexican conditional cash transfer program “Oportuni-
dades” has also had a positive impact on health outcomes
and vaccination coverage among elders [37].
Few studies have focused on the impact of social pro-
tection policies on infectious disease burden, especially
TB burden. Experimental provision of food baskets was
associated to increased TB treatment completion and
cure rates in Brazil [38]. There is also evidence showing
a 7% higher cure rate among “Bolsa Família” beneficiares
in Brazil [39], and a positive impact of social protection
interventions (CRESIPT project) on catastrophic cost in
poor households in Peru [40]. Siroka et al. [40] also
suggested a strong negative correlation between expen-
ditures as gross domestic product (GDP) percentage in
social protection programs for poverty alleviation and
TB rates (for incidence, prevalence and mortality) [41].
There is lack of data about social protection policies
among migrants, but we suggest that poor migrants
should be offered what is offered to poor locally born
people. In Mercosul4, migrants have the same rights as
nationals [42] and legal residents in Brazil can access
CCT programs if poverty criteria are met, but irregular
migrants, which could include person with free
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movement but under irregular labour conditions, con-
tinue to be poorer and neglected. Non-criminalization of
migration is an essential effort to give migrants an op-
portunity to improve their economic status and conse-
quently their health. To extend social protection benefits
to migrants who meet delimited poverty criteria during
TB treatment will improve migrant and community
health. We suggest that social protection could be
integrated into control programs and active TB
screening among household contacts for example act
as conditionalities. These actions must assure confi-
dentiality to guarantee the absence of additional bar-
riers to employment and protect migrants from being
deported after treatment completion.
In middle-income countries with marked social
inequalities such as Brazil, control strategies would be
more successful if they take into account the intricacies
of TB, placing control policies within the broader context
of health care and social equity. Despite differences be-
tween public policies to promote social and health equity
in Brazil and the circumstances in other middle-income
countries, we believe that social protection policies must
incorporate TB control strategies and a migration-related
component. Migrants’ sociodemographic aspects, TB
morbidity and mortality and migratory patterns specific to
each country must be taken into account.
The advantages of an intersectoral approach to control
TB among migrants
The United Nations post-2015 agenda established more
ambitious health targets and called for intersectoral
policies. Since TB is a disease of poverty, predominantly
affecting people living in large cities, and recognizing
the wide heterogeneity existing between middle-income
countries and source countries of migrants, from labour
migrants to refugees, it is key to establish TB control pro-
grams alongside intersectoral public policies that promote
social equity. Conditional cash transfer programs inte-
grated into active TB screening and strong contact tracing
could have a positive impact on TB control among the
poorest and most vulnerable populations.
Cooperation and technology transfer among the
BRICS and other low- and middle-income countries
would also advance the control of neglected diseases
[43]. These countries have reached agreements for
cooperation and technology transfer for the control of
neglected diseases, which points to greater integration
and sharing innovation to the production of health in-
puts for TB control programs [43]. Some technical
agreements between South American countries medi-
ated by PAHO/WHO have given support to improve
public primary health care programs in Paraguay and in
the Andes regions [44]. Such strategies could be an
example to other South-South cooperation initiatives.
These notable initiatives could be expanded to include
more specific targets for TB control, as improving health
care may not be sufficient to guarantee equity in access
for migrants. Old and new TB control strategies may
not have the desired impact unless there are initiatives
for poverty reduction and early disease diagnosis among
migrants. Moreover, because middle-income countries
have limited health care resources, established health
policies may be compromised if there is an increased
demand due to migration and intersectoral policies are
not planned.
Conclusions
Middle-income countries and especially UMIC have
been facing the same phenomena as seen in high-
income countries in past decades: labour migration to
large urban cities. Because of marked inequalities, big
cities from middle-income countries must prepare to
provide health care to incoming migrants, building on
the reverse experience of being primarily a source of
migration to more developed regions. In this context,
intersectoral TB control strategies are needed to address
social and health inequalities taking into account both
migrants and locally born vulnerable groups in these
countries. Conditional cash transfer policies may benefit
poor migrants, especially during the first years after
migration, and improve access to health care. Strength-
ening of DOTS and TB screening must also include
migrants, especially irregular migrants that might not be
supported by CCT programs. Finally, since migration
flows largely take place within or between neighbouring
regions [45], innovative control measures integrated with
intersectoral and international policies are crucial for TB
control and must be prioritized in regional agreements.
Sending and receiving nations should channel their
efforts to further integrating their health policies.
Endnotes
1Although difficult to define, vulnerable groups
include communities that are more vulnerable to conflicts,
health conditions or economic shocks: people living in ex-
treme poverty or socially excluded individuals, migrants
or specific populations such as children, women and
people with disabilities.
2Russia is part of the BRICS group though it has been
classified as high-income since 2013 and as upper-
middle again in 2016.
3Among a variety of definitions, “South” generally
denotes low- to middle-income countries while “North”
refers to high-income countries.
4Mercosur full members include Argentina, Brazil,
Bolivia, Paraguay, Uruguay and Venezuela. Associate
members include Chile, Peru, Colombia, Ecuador,
Guyana and Suriname (Mercosul, [46]).
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